Ready to learn more about DAYVIGO™? Fill out the form below
to get started.
Terms and Conditions
Please be advised that the personal information you provide will be used to satisfy
your request to receive information from Eisai Inc. Eisai Inc. (“Eisai” or “we”) operates
this website and our Privacy Policy will govern the collection, use, disclosure and
retention of the information you provide here. Please do not submit any personal
information unless you have read and agree with the terms of that Privacy Policy.
Consistent with the Privacy Policy, we and our service providers may use the personal
information you provide to contact you and send your communications, including
about products and services that may interest you. By clicking Submit below you
agree that you have read, understand, and agree to these conditions.
In the event that you would like to opt out of receiving further communications, you
can request that you be removed from the Eisai contact list at any time by clicking on
the “Unsubscribe” link found at the bottom of all email communications from Eisai. See
our full Privacy Policy.
Submit
Your Request Is In!
Thank you for reaching out. An Eisai representative will connect with you soon to help you learn more about DAYVIGO™.
Sorry!
Something went wrong during the processing of your request.
Please come back later and try again.
Already Registered
Our records show that this email address has already been registered.
Sleep disturbance may be the presenting manifestation of a physical and/or psychiatric disorder.
Consequently, a decision to initiate symptomatic treatment of insomnia should only be made after the
patient has been carefully evaluated.
DAYVIGO™ is indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or
sleep maintenance.
Click here for additional safety information and for a link to the product monograph, discussing
contraindications, warnings, precautions, adverse reactions, interactions, dosing, and conditions of clinical
use.